Trials / Completed
CompletedNCT03664310
Transdiagnostic Sleep and Anxiety Treatment
A Pilot Study and Randomized Controlled Trial of Transdiagnostic Sleep and Anxiety Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Florida State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FSET Anxiety and Sleep Treatment | Computerized anxiety and insomnia intervention. |
| OTHER | Control | Physical health control |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-05-12
- Completion
- 2018-05-12
- First posted
- 2018-09-10
- Last updated
- 2021-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03664310. Inclusion in this directory is not an endorsement.